If SSTR-2, SSTR-3 and SSTR-5 are not expressed or have a low tumor expression, SSAs can lead to paradoxical hypoglycemia because they also inhibit counterregulatory hormone secretion (i.e., glucagon and growth hormone) [115,117]. Here, GH1 is linked to neoplasm.